300 related articles for article (PubMed ID: 9193835)
1. Prognostic factors and early resumption of cyclosporin A in renal allograft recipients with thrombotic microangiopathy and hemolytic uremic syndrome.
Wiener Y; Nakhleh RE; Lee MW; Escobar FS; Venkat KK; Kupin WL; Mozes MF
Clin Transplant; 1997 Jun; 11(3):157-62. PubMed ID: 9193835
[TBL] [Abstract][Full Text] [Related]
2. A case of late onset cyclosporine-induced hemolytic uremic syndrome resulting in renal graft loss.
Katafuchi R; Saito S; Ikeda K; Hirano T; Yanase T; Nakashima K; Fujimi S
Clin Transplant; 1999; 13 Suppl 1():54-8. PubMed ID: 10751058
[TBL] [Abstract][Full Text] [Related]
3. Follow-up of kidney graft recipients with cyclosporine-associated hemolytic-uremic syndrome and thrombotic microangiopathy.
Bren A; Pajek J; Grego K; Buturovic J; Ponikvar R; Lindic J; Knap B; Vizjak A; Ferluga D; Kandus A
Transplant Proc; 2005 May; 37(4):1889-91. PubMed ID: 15919494
[TBL] [Abstract][Full Text] [Related]
4. Postrenal transplant hemolytic uremic syndrome/thrombotic microangiopathy: Ahmedabad experience.
Goplani KR; Vanikar AV; Shah PR; Gumber M; Feroz A; Patel HV; Kasat P; Falodia J; Saboo D; Kaswaan K; Geerish MS; Pandya T; Trivedi HL
Transplant Proc; 2008 May; 40(4):1114-6. PubMed ID: 18555127
[TBL] [Abstract][Full Text] [Related]
5. De novo thrombotic microangiopathy in renal transplant recipients: a comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy.
Schwimmer J; Nadasdy TA; Spitalnik PF; Kaplan KL; Zand MS
Am J Kidney Dis; 2003 Feb; 41(2):471-9. PubMed ID: 12552512
[TBL] [Abstract][Full Text] [Related]
6. Posttransplantation calcineurin inhibitor-induced hemolytic uremic syndrome: single-center experience.
Said T; Al-Otaibi T; Al-Wahaib S; Francis I; Nair MP; Halim MA; El-Sayed A; Nampoory MR
Transplant Proc; 2010 Apr; 42(3):814-6. PubMed ID: 20430179
[TBL] [Abstract][Full Text] [Related]
7. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function.
Sumrani N; Hong JH; DiBenedetto A; Clayton R; Miles AM; Markell MS; Distant DA; Fleishhacker J; Sommer BG
Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289
[No Abstract] [Full Text] [Related]
8. Shiga toxin-associated hemolytic uremic syndrome: absence of recurrence after renal transplantation.
Ferraris JR; Ramirez JA; Ruiz S; Caletti MG; Vallejo G; Piantanida JJ; Araujo JL; Sojo ET
Pediatr Nephrol; 2002 Oct; 17(10):809-14. PubMed ID: 12376808
[TBL] [Abstract][Full Text] [Related]
9. [Hemolytic-uremic syndrome following kidney transplantation: prognostic factors].
Candinas D; Keusch G; Schlumpf R; Burger HR; Gmür J; Largiadèr F
Schweiz Med Wochenschr; 1994 Oct; 124(41):1789-99. PubMed ID: 7973505
[TBL] [Abstract][Full Text] [Related]
10. Renal transplantation in patients with hemolytic uremic syndrome: high rate of recurrence and increased incidence of acute rejections.
Artz MA; Steenbergen EJ; Hoitsma AJ; Monnens LA; Wetzels JF
Transplantation; 2003 Sep; 76(5):821-6. PubMed ID: 14501861
[TBL] [Abstract][Full Text] [Related]
11. De novo thrombotic microangiopathy after kidney transplantation: clinical features, treatment, and long-term patient and graft survival.
Caires RA; Marques ID; Repizo LP; Sato VA; Carmo LP; Machado DJ; de Paula FJ; Nahas WC; David-Neto E
Transplant Proc; 2012 Oct; 44(8):2388-90. PubMed ID: 23026601
[TBL] [Abstract][Full Text] [Related]
12. Proteinuria in renal transplant recipients: incidence, cause, and prognostic importance.
Kim HC; Park SB; Lee SH; Park KK; Park CH; Cho WH
Transplant Proc; 1994 Aug; 26(4):2134-5. PubMed ID: 8066696
[No Abstract] [Full Text] [Related]
13. Tacrolimus-associated hemolytic uremic syndrome: a case analysis.
Lin CC; King KL; Chao YW; Yang AH; Chang CF; Yang WC
J Nephrol; 2003; 16(4):580-5. PubMed ID: 14696762
[TBL] [Abstract][Full Text] [Related]
14. Graft outcome in cadaver renal transplants treated with full-dose cyclosporine induction without antibody, irrespective of graft function.
Douzdjian V; Bhaskar S; Baliga PK; Rajagopalan PR
Clin Transplant; 1997 Aug; 11(4):294-8. PubMed ID: 9267718
[TBL] [Abstract][Full Text] [Related]
15. Annual trends and triple therapy--1991-2000.
Nishikawa K; Terasaki PI
Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
[TBL] [Abstract][Full Text] [Related]
16. Steroid withdrawal in kidney transplant recipients: is it a safe option?
Sanfey H; Haussman G; Isaacs I; Ishitani M; Lobo P; McCullough C; Pruett T
Clin Transplant; 1997 Oct; 11(5 Pt 2):500-4. PubMed ID: 9361950
[TBL] [Abstract][Full Text] [Related]
17. Effect of early cyclosporine levels on kidney allograft rejection.
Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
[TBL] [Abstract][Full Text] [Related]
18. Thrombotic microangiopathy in the early post-renal transplant period.
Ardalan MR; Shoja MM; Tubbs RS; Etemadi J; Esmaili H; Khosroshahi HT
Ren Fail; 2008; 30(2):199-203. PubMed ID: 18300121
[TBL] [Abstract][Full Text] [Related]
19. Renal allograft function and results with cyclosporine immunosuppression in recipients of single kidneys from cadaveric donors aged 12 to 24 months.
Banowsky LH; Wright FH; Kothmann R; Floyd M; Vick S
Transplant Proc; 1996 Aug; 28(4):2121-4. PubMed ID: 8769175
[No Abstract] [Full Text] [Related]
20. [Thrombotic microangiopathy after kidney transplantation].
Basić-Jukić N; Jurić I; Brunetta-Gavranić B; Kes P; Bubić-Filipi L; Glavas-Boras S
Acta Med Croatica; 2008; 62 Suppl 1():93-6. PubMed ID: 18578340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
